Design, Synthesis and Biological Potential of Heterocyclic Benzoxazole Scaffolds As Promising Antimicrobial and Anticancer Agents

Overview

Journal Chem Cent J

Publisher Biomed Central

Specialty Chemistry

Date 2018 Sep 21

PMID 30232633

Citations 10

Authors

Saloni Kakkar

Sanjiv Kumar

Balasubramanian Narasimhan

Siong Meng Lim

Kalavathy Ramasamy

Vasudevan Mani

Syed Adnan Ali Shah

Affiliations

Soon will be listed here.

Abstract

Background: Benzoxazole is the most important class of heterocyclic compound in medicinal chemistry. It has been incorporated in many medicinal compounds making it a versatile heterocyclic compound that possess a wide spectrum of biological activities.

Results: The molecular structures of synthesized benzoxazole derivatives were confirmed by physicochemical and spectral means. The synthesized compounds were further evaluated for their in vitro biological potentials i.e. antimicrobial activity against selected microbial species using tube dilution method and antiproliferative activity against human colorectal carcinoma (HCT 116) cancer cell line by Sulforhodamine B assay.

Conclusion: In vitro antimicrobial results demonstrated that compounds 4, 5, 7 and 16 showed promising antimicrobial potential. The in vitro anticancer activity indicated that compounds 4 and 16 showed promising anticancer activity against human colorectal cancer cell line (HCT 116) when compared to standard drug and these compounds may serve as lead compound for further development of novel antimicrobial and anticancer agents.

Citing Articles

New pyridopyrimidine derivatives as dual EGFR and CDK4/cyclin D1 inhibitors: synthesis, biological screening and molecular modeling.

Krakisha F, Othman D, El Husseiny W, Nasr M Future Med Chem. 2024; 16(16):1633-1648.

PMID: 39023284 PMC: 11370904. DOI: 10.1080/17568919.2024.2366147.

Benzazole-Based ESIPT Fluorophores: Proton Transfer from the Chalcogen Perspective. A Combined Theoretical and Experimental Study.

Reimann L, Dalberto B, Schneider P, de Castro Silva Junior H, Rodembusch F J Fluoresc. 2024; .

PMID: 38507128 DOI: 10.1007/s10895-024-03595-y.

Computational Studies and Antimicrobial Activity of 1-(benzo[d]oxazol-2- yl)-3,5-diphenylformazan Derivatives.

Almehmadi M, Alsaiari A, Allahyani M, Alsharif A, Aljuaid A, Saha S Curr Comput Aided Drug Des. 2023; 20(6):835-846.

PMID: 37403393 DOI: 10.2174/1573409919666230703103135.

Imine Derivatives of Benzoxazole Attenuate High-Fat Diet-Induced Hyperlipidemia by Modulation of Lipid-Regulating Genes.

Zaib M, Malik M, Shabbir R, Mushtaq M, Younis W, Jahan S ACS Omega. 2023; 8(17):15306-15317.

PMID: 37151544 PMC: 10157695. DOI: 10.1021/acsomega.3c00443.

Design, Synthesis, and Anti-Fungal Evaluation of Heterocyclic Benzoxazole Derivatives.

Wang R, Kang R, Yang X, Cheng Y, Bai H, Du Z Molecules. 2022; 27(23).

PMID: 36500467 PMC: 9739801. DOI: 10.3390/molecules27238375.

References

Ashton W, Sisco R, Dong H, Lyons K, He H, Doss G . Dipeptidyl peptidase IV inhibitors derived from beta-aminoacylpiperidines bearing a fused thiazole, oxazole, isoxazole, or pyrazole. Bioorg Med Chem Lett. 2005; 15(9):2253-8. DOI: 10.1016/j.bmcl.2005.03.012. View

Lin J, Shen W, Xue J, Sun J, Zhang X, Zhang C . Novel oxazolo[4,5-g]quinazolin-2(1H)-ones: dual inhibitors of EGFR and Src protein tyrosine kinases. Eur J Med Chem. 2012; 55:39-48. DOI: 10.1016/j.ejmech.2012.06.055. View

Moura K, Carneiro P, Pinto M, da Silva J, Malta V, De Simone C . 1,3-Azoles from ortho-naphthoquinones: synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis. Bioorg Med Chem. 2012; 20(21):6482-8. DOI: 10.1016/j.bmc.2012.08.041. View

Zhang W, Liu W, Jiang X, Jiang F, Zhuang H, Fu L . Design, synthesis and antimicrobial activity of chiral 2-(substituted-hydroxyl)-3-(benzo[d]oxazol-5-yl)propanoic acid derivatives. Eur J Med Chem. 2011; 46(9):3639-50. DOI: 10.1016/j.ejmech.2011.05.028. View

Kakkar S, Tahlan S, Lim S, Ramasamy K, Mani V, Shah S . Benzoxazole derivatives: design, synthesis and biological evaluation. Chem Cent J. 2018; 12(1):92. PMC: 6087707. DOI: 10.1186/s13065-018-0459-5. View

Hernandez D, Altuna M, Cuevas C, Aligue R, Albericio F, Alvarez M . Synthesis and antitumor activity of mechercharmycin A analogues. J Med Chem. 2008; 51(18):5722-30. DOI: 10.1021/jm800513w. View

Yothers G, OConnell M, Lee M, Lopatin M, Clark-Langone K, Millward C . Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU/LV) and FU/LV plus oxaliplatin. J Clin Oncol. 2013; 31(36):4512-9. PMC: 3871512. DOI: 10.1200/JCO.2012.47.3116. View

Kumar S, Lim S, Ramasamy K, Mani V, Shah S, Narasimhan B . Design, synthesis, antimicrobial and cytotoxicity study on human colorectal carcinoma cell line of new 4,4'-(1,4-phenylene)bis(pyrimidin-2-amine) derivatives. Chem Cent J. 2018; 12(1):73. PMC: 6020093. DOI: 10.1186/s13065-018-0440-3. View

Stein A, Hiemer S, Schmoll H . Adjuvant therapy for early colon cancer: current status. Drugs. 2011; 71(17):2257-75. DOI: 10.2165/11594490-000000000-00000. View

10.

Parkin D, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108. DOI: 10.3322/canjclin.55.2.74. View

11.

Niu J, Su Z, Xiao Y, Huang A, Li H, Bao X . Octreotide-modified and pH-triggering polymeric micelles loaded with doxorubicin for tumor targeting delivery. Eur J Pharm Sci. 2011; 45(1-2):216-26. DOI: 10.1016/j.ejps.2011.11.013. View

12.

Eren G, Unlu S, Nunez M, Labeaga L, Ledo F, Entrena A . Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors. Bioorg Med Chem. 2010; 18(17):6367-76. DOI: 10.1016/j.bmc.2010.07.009. View

13.

Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D . New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990; 82(13):1107-12. DOI: 10.1093/jnci/82.13.1107. View

14.

Kumar S, Lim S, Ramasamy K, Vasudevan M, Shah S, Narasimhan B . Bis-pyrimidine acetamides: design, synthesis and biological evaluation. Chem Cent J. 2017; 11(1):80. PMC: 5548699. DOI: 10.1186/s13065-017-0312-2. View

15.

Brandy Y, Ononiwu I, Adedeji D, Williams V, Mouamba C, Kanaan Y . Synthesis and cytotoxic activities of some 2-arylnaphtho[2,3-d]oxazole-4,9-dione derivatives on androgen-dependent (LNCaP) and androgen-independent (PC3) human prostate cancer cell lines. Invest New Drugs. 2011; 30(4):1709-14. PMC: 3756683. DOI: 10.1007/s10637-011-9635-3. View

16.

Pilch D, Barbieri C, Rzuczek S, LaVoie E, Rice J . Targeting human telomeric G-quadruplex DNA with oxazole-containing macrocyclic compounds. Biochimie. 2008; 90(8):1233-49. PMC: 2587169. DOI: 10.1016/j.biochi.2008.03.011. View

17.

Ryu C, Lee R, Kim N, Kim Y, Song A . Synthesis and antifungal activity of benzo[d]oxazole-4,7-diones. Bioorg Med Chem Lett. 2009; 19(20):5924-6. DOI: 10.1016/j.bmcl.2009.08.062. View

18.

Kamal A, Dastagiri D, Ramaiah M, Reddy J, Vijaya Bharathi E, Reddy M . Synthesis and apoptosis inducing ability of new anilino substituted pyrimidine sulfonamides as potential anticancer agents. Eur J Med Chem. 2011; 46(12):5817-24. DOI: 10.1016/j.ejmech.2011.09.039. View

19.

Ychou M, Hohenberger W, Thezenas S, Navarro M, Maurel J, Bokemeyer C . A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol. 2009; 20(12):1964-70. DOI: 10.1093/annonc/mdp236. View

20.

Padmavathi V, Prema Kumari C, Venkatesh B, Padmaja A . Synthesis and antimicrobial activity of amido linked pyrrolyl and pyrazolyl-oxazoles, thiazoles and imidazoles. Eur J Med Chem. 2011; 46(11):5317-26. DOI: 10.1016/j.ejmech.2011.08.032. View